MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight
Location: Canada, Ontario, Toronto
Employees: 11-50
Phone: +1 647-362-4684
Total raised: $21.7M
Founded date: 2013
Investors 1
| Date | Name | Website |
| 05.01.2022 | SWK Holdin... | swkhold.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.08.2024 | Series C | $11.7M | - |
| 05.01.2022 | - | $10M | SWK Holdin... |
Mentions in press and media 14
| Date | Title | Description |
| 23.08.2024 | MolecuLight: Point-Of-Care Fluorescence Imaging Company Raises $11.7 Million (Series C) | MolecuLight, a leader in point-of-care fluorescence imaging, announced the closing of a $11.7 million Series C funding round led by new investors Export Development Canada (EDC), Prosegur, and Azahar. Existing investors also participated in... |
| 16.08.2024 | MolecuLight Raises $11.7M in Series C Financing | MolecuLight, a Toronto, Canada-based point-of-care fluorescence imaging company, raised $11.7M in Series C funding. The round was led by Export Development Canada (EDC), Prosegur, and Azahar. Existing investors also participated. The compan... |
| 15.08.2024 | MolecuLight Secures $11.7 Million in Financing to Accelerate Global Expansion | TORONTO, Aug. 15, 2024 /PRNewswire/ - MolecuLight Inc., a leader in point-of-care fluorescence imaging, today announced the closing of a $11.7 million Series C financing round led by new investors Export Development Canada (EDC), Prosegur, ... |
| 13.08.2024 | MolecuLight's Breakthrough Imaging Technology Promotes Health Equity in Wound Care | Pittsburgh, Pa., Aug. 13, 2024 /PRNewswire/ - MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, is proudly reaffirmed in their commitment to equitable wound ca... |
| 06.08.2024 | MolecuLight's Profound Impact on Wound Healing Highlighted in Breaking Clinical Research | PITTSBURGH, Aug. 6, 2024 /PRNewswire/ - MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, announces the publication of peer-reviewed clinical research highligh... |
| 05.06.2024 | Advanced Wound Care Market Projected to Reach Valuation of USD 17.8 billion at 5.6% CAGR from 2024-2032 | Advanced Wound Care Market 2033 PORTLAND, OREGON, UNITED STATES, June 5, 2024 /EINPresswire.com/ -- What is the future of advanced wound care? According to the report, the global advanced wound care market generated $10.3 billion in 2022, a... |
| 13.05.2024 | MolecuLight's Innovative Approach Awarded Best Abstract at EWMA 2024 | TORONTO, May 13, 2024 /PRNewswire/ - MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, is proud to announce that a groundbreaking study led by Dr. Rosemarie Der... |
| 26.01.2023 | The advanced wound care market is valued at an estimated USD 11.3 billion in 2022 and is projected to reach USD 17.7 billion by 2027, at a CAGR of 9.4% | - |
| 15.08.2022 | MolecuLight Secures Financing from BDC Canada and iGan Partners | MolecuLight, a Toronto, Canada-based provider of point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, raised an undisclosed amount in funding. The round was led by BDC Capital and iGan Ve... |
| 08.04.2021 | MolecuLight Announces the Appointment of 11 Global Distributors |
Show more